JP2010501587A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010501587A5 JP2010501587A5 JP2009525728A JP2009525728A JP2010501587A5 JP 2010501587 A5 JP2010501587 A5 JP 2010501587A5 JP 2009525728 A JP2009525728 A JP 2009525728A JP 2009525728 A JP2009525728 A JP 2009525728A JP 2010501587 A5 JP2010501587 A5 JP 2010501587A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- phenoxy
- acetic acid
- methyl
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 1,2,3,4-tetrahydronaphthyl Chemical group 0.000 claims description 91
- 150000001875 compounds Chemical class 0.000 claims description 89
- 125000000217 alkyl group Chemical group 0.000 claims description 54
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims description 27
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 26
- 229910052731 fluorine Inorganic materials 0.000 claims description 26
- 230000000875 corresponding Effects 0.000 claims description 22
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 229910052801 chlorine Inorganic materials 0.000 claims description 14
- 125000005843 halogen group Chemical group 0.000 claims description 14
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 12
- 125000001624 naphthyl group Chemical group 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims description 10
- 125000001544 thienyl group Chemical group 0.000 claims description 10
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 8
- 206010021425 Immune system disease Diseases 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 125000000623 heterocyclic group Chemical group 0.000 claims description 8
- 125000004429 atoms Chemical group 0.000 claims description 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 6
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 6
- 229910052794 bromium Inorganic materials 0.000 claims description 6
- 125000006575 electron-withdrawing group Chemical group 0.000 claims description 6
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 6
- 125000003386 piperidinyl group Chemical group 0.000 claims description 6
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 6
- 230000001808 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 4
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 4
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 4
- 108010016626 Dipeptides Chemical group 0.000 claims description 4
- 150000001413 amino acids Chemical group 0.000 claims description 4
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 125000005842 heteroatoms Chemical group 0.000 claims description 4
- 125000002883 imidazolyl group Chemical group 0.000 claims description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 2
- LFLSATHZMYYIAQ-UHFFFAOYSA-N 4-Flourobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(F)C=C1 LFLSATHZMYYIAQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- 125000000590 4-methylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims description 2
- 125000006164 6-membered heteroaryl group Chemical group 0.000 claims description 2
- 206010003210 Arteriosclerosis Diseases 0.000 claims description 2
- 208000006673 Asthma Diseases 0.000 claims description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims description 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 2
- 206010010741 Conjunctivitis Diseases 0.000 claims description 2
- 206010011401 Crohn's disease Diseases 0.000 claims description 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 2
- 206010012601 Diabetes mellitus Diseases 0.000 claims description 2
- 208000005679 Eczema Diseases 0.000 claims description 2
- 208000010201 Exanthema Diseases 0.000 claims description 2
- 206010016654 Fibrosis Diseases 0.000 claims description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims description 2
- 206010027665 Immune disorder Diseases 0.000 claims description 2
- 206010061218 Inflammation Diseases 0.000 claims description 2
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 206010028735 Nasal congestion Diseases 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 claims description 2
- 206010037660 Pyrexia Diseases 0.000 claims description 2
- 206010037844 Rash Diseases 0.000 claims description 2
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims description 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 2
- 208000007536 Thrombosis Diseases 0.000 claims description 2
- 206010052779 Transplant rejections Diseases 0.000 claims description 2
- 206010046736 Urticarias Diseases 0.000 claims description 2
- 206010047461 Viral infection Diseases 0.000 claims description 2
- 208000001756 Virus Disease Diseases 0.000 claims description 2
- 125000006383 alkylpyridyl group Chemical group 0.000 claims description 2
- 201000010105 allergic rhinitis Diseases 0.000 claims description 2
- 201000001320 atherosclerosis Diseases 0.000 claims description 2
- 201000008937 atopic dermatitis Diseases 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 201000004624 dermatitis Diseases 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 231100001003 eczema Toxicity 0.000 claims description 2
- 238000003379 elimination reaction Methods 0.000 claims description 2
- 201000005884 exanthem Diseases 0.000 claims description 2
- 230000004761 fibrosis Effects 0.000 claims description 2
- 238000011010 flushing procedure Methods 0.000 claims description 2
- 150000004820 halides Chemical group 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 claims description 2
- 230000004968 inflammatory condition Effects 0.000 claims description 2
- 230000004054 inflammatory process Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 201000006417 multiple sclerosis Diseases 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 201000004681 psoriasis Diseases 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 201000006704 ulcerative colitis Diseases 0.000 claims description 2
- 230000017613 viral reproduction Effects 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 3
- SUVXKBPDKSACKX-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 SUVXKBPDKSACKX-UHFFFAOYSA-N 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- XVQDYPCNGOHWRO-UHFFFAOYSA-N 2-[3-(acetamidomethyl)-4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]phenyl]acetic acid Chemical compound CC(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 XVQDYPCNGOHWRO-UHFFFAOYSA-N 0.000 claims 1
- UOKSQLHHEOQAPZ-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-(2-phenylethylcarbamoyl)phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC=CC=2)C=C1 UOKSQLHHEOQAPZ-UHFFFAOYSA-N 0.000 claims 1
- HCMUIRXYFFKCSZ-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-(naphthalen-2-ylcarbamoyl)phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=C3C=CC=CC3=CC=2)C=C1 HCMUIRXYFFKCSZ-UHFFFAOYSA-N 0.000 claims 1
- FRJYUTCPJMAZSA-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-(phenylcarbamoyl)phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=CC=CC=2)C=C1 FRJYUTCPJMAZSA-UHFFFAOYSA-N 0.000 claims 1
- RJTWDVHVVUEUGD-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-(phenylmethoxycarbamoyl)phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NOCC=2C=CC=CC=2)C=C1 RJTWDVHVVUEUGD-UHFFFAOYSA-N 0.000 claims 1
- OZKQHSUPRRZQNJ-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-[2-[3-(trifluoromethyl)phenyl]ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=C(C=CC=2)C(F)(F)F)C=C1 OZKQHSUPRRZQNJ-UHFFFAOYSA-N 0.000 claims 1
- SZSFSDUCABQSLK-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-[2-oxo-2-(2-phenylethylamino)ethyl]phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1CC(=O)NCCC1=CC=CC=C1 SZSFSDUCABQSLK-UHFFFAOYSA-N 0.000 claims 1
- XOBGYGVFYXMLPS-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-[[3-(trifluoromethyl)phenyl]carbamoyl]phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)C=C1 XOBGYGVFYXMLPS-UHFFFAOYSA-N 0.000 claims 1
- ZTOUDBPQHWAQKU-UHFFFAOYSA-N 2-[3-(methanesulfonamidomethyl)-4-[4-[[4-(trifluoromethyl)phenyl]carbamoyl]phenoxy]phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)C=C1 ZTOUDBPQHWAQKU-UHFFFAOYSA-N 0.000 claims 1
- ZCEDRLJHNKDRBJ-UHFFFAOYSA-N 2-[3-[(cyclohexanecarbonylamino)methyl]-4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]phenyl]acetic acid Chemical compound C1CCCCC1C(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 ZCEDRLJHNKDRBJ-UHFFFAOYSA-N 0.000 claims 1
- RLGVKZNWDLMRCZ-UHFFFAOYSA-N 2-[3-[[(6-aminopyridine-3-carbonyl)amino]methyl]-4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound C1=NC(N)=CC=C1C(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 RLGVKZNWDLMRCZ-UHFFFAOYSA-N 0.000 claims 1
- WHQIQLCTPHJMRM-UHFFFAOYSA-N 2-[3-bromo-4-[4-[2-(2,4-dichlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound BrC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C(=CC(Cl)=CC=2)Cl)C=C1 WHQIQLCTPHJMRM-UHFFFAOYSA-N 0.000 claims 1
- FPIWVZSIJRTVRS-UHFFFAOYSA-N 2-[3-chloro-4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound ClC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 FPIWVZSIJRTVRS-UHFFFAOYSA-N 0.000 claims 1
- WZDDSKHKSNYVSZ-UHFFFAOYSA-N 2-[3-cyano-4-[4-(1,2,3,4-tetrahydronaphthalen-2-ylcarbamoyl)phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NC2CC3=CC=CC=C3CC2)C=C1 WZDDSKHKSNYVSZ-UHFFFAOYSA-N 0.000 claims 1
- BBHSEVSJFHURJU-UHFFFAOYSA-N 2-[3-cyano-4-[4-(2-phenylethylcarbamoyl)phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC=CC=2)C=C1 BBHSEVSJFHURJU-UHFFFAOYSA-N 0.000 claims 1
- QPVWRFSVMBTLNG-UHFFFAOYSA-N 2-[3-cyano-4-[4-[(2-phenylcyclopropyl)carbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NC2C(C2)C=2C=CC=CC=2)C=C1 QPVWRFSVMBTLNG-UHFFFAOYSA-N 0.000 claims 1
- KWCRHELWBLSJSW-UHFFFAOYSA-N 2-[3-cyano-4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]phenyl]propanoic acid Chemical compound N#CC1=CC(C(C(O)=O)C)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 KWCRHELWBLSJSW-UHFFFAOYSA-N 0.000 claims 1
- KJUDCCWJLHWIDB-UHFFFAOYSA-N 2-[3-cyano-4-[4-[(6-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)carbamoyl]phenoxy]phenyl]acetic acid Chemical compound C1CC2=CC(OC)=CC=C2CC1NC(=O)C(C=C1)=CC=C1OC1=CC=C(CC(O)=O)C=C1C#N KJUDCCWJLHWIDB-UHFFFAOYSA-N 0.000 claims 1
- LRSHPFBLIYGFMF-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(2,4-dichlorophenyl)ethylcarbamoyl]-3-fluorophenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC(C=C1F)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1Cl LRSHPFBLIYGFMF-UHFFFAOYSA-N 0.000 claims 1
- GQWUXWGRBCQNGK-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(2,4-dichlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C(=CC(Cl)=CC=2)Cl)C=C1 GQWUXWGRBCQNGK-UHFFFAOYSA-N 0.000 claims 1
- VBUAISCHCBVIEQ-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(2,6-dichlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C(=CC=CC=2Cl)Cl)C=C1 VBUAISCHCBVIEQ-UHFFFAOYSA-N 0.000 claims 1
- VLVMNNNLIJZNJT-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(3,4-dichlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=C(Cl)C(Cl)=CC=2)C=C1 VLVMNNNLIJZNJT-UHFFFAOYSA-N 0.000 claims 1
- HLCMSNAONPTSTC-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(3-fluorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=C(F)C=CC=2)C=C1 HLCMSNAONPTSTC-UHFFFAOYSA-N 0.000 claims 1
- UMPPTBPWPCPZFQ-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(3-methoxyphenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound COC1=CC=CC(CCNC(=O)C=2C=CC(OC=3C(=CC(CC(O)=O)=CC=3)C#N)=CC=2)=C1 UMPPTBPWPCPZFQ-UHFFFAOYSA-N 0.000 claims 1
- RCXKIHBEWQEVNI-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(4-fluorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(F)=CC=2)C=C1 RCXKIHBEWQEVNI-UHFFFAOYSA-N 0.000 claims 1
- OQIFQHIGUKXNQT-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(4-methoxyphenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound C1=CC(OC)=CC=C1CCNC(=O)C(C=C1)=CC=C1OC1=CC=C(CC(O)=O)C=C1C#N OQIFQHIGUKXNQT-UHFFFAOYSA-N 0.000 claims 1
- VNTMJVRXRDIATN-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-(4-methylphenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound C1=CC(C)=CC=C1CCNC(=O)C(C=C1)=CC=C1OC1=CC=C(CC(O)=O)C=C1C#N VNTMJVRXRDIATN-UHFFFAOYSA-N 0.000 claims 1
- JCFCADMRGFDULV-UHFFFAOYSA-N 2-[3-cyano-4-[4-[2-[4-(trifluoromethyl)phenyl]ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(=CC=2)C(F)(F)F)C=C1 JCFCADMRGFDULV-UHFFFAOYSA-N 0.000 claims 1
- HZKIFJONYKLHSP-UHFFFAOYSA-N 2-[4-(4-benzamidophenoxy)-3-[[(4-fluorophenyl)sulfonylamino]methyl]phenyl]acetic acid Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1 HZKIFJONYKLHSP-UHFFFAOYSA-N 0.000 claims 1
- PJPFNAJCEXEVPS-UHFFFAOYSA-N 2-[4-[4-(2-anilino-2-oxoethyl)phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1CC(=O)NC1=CC=CC=C1 PJPFNAJCEXEVPS-UHFFFAOYSA-N 0.000 claims 1
- HZWZALRGUIUJMY-UHFFFAOYSA-N 2-[4-[4-(benzylcarbamoyl)phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCC=2C=CC=CC=2)C=C1 HZWZALRGUIUJMY-UHFFFAOYSA-N 0.000 claims 1
- XESKULREWPZSAU-UHFFFAOYSA-N 2-[4-[4-[(2-chlorobenzoyl)amino]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=CC=C1Cl XESKULREWPZSAU-UHFFFAOYSA-N 0.000 claims 1
- WVFFCOFGRIUMDE-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-(methanesulfonamidomethyl)phenyl]-2-methylpropanoic acid Chemical compound CS(=O)(=O)NCC1=CC(C(C)(C(O)=O)C)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 WVFFCOFGRIUMDE-UHFFFAOYSA-N 0.000 claims 1
- GCHRMDXBRYDDDO-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-(methanesulfonamidomethyl)phenyl]propanoic acid Chemical compound CS(=O)(=O)NCC1=CC(C(C(O)=O)C)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 GCHRMDXBRYDDDO-UHFFFAOYSA-N 0.000 claims 1
- FAQRSMNNJBHVRN-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[(methoxycarbonylamino)methyl]phenyl]acetic acid Chemical compound COC(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 FAQRSMNNJBHVRN-UHFFFAOYSA-N 0.000 claims 1
- AZABPOZXQMDWKR-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[(pyridin-3-ylsulfonylamino)methyl]phenyl]acetic acid Chemical compound C=1C=CN=CC=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 AZABPOZXQMDWKR-UHFFFAOYSA-N 0.000 claims 1
- XDHAIXLWGSULRW-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[(pyridine-2-carbonylamino)methyl]phenyl]acetic acid Chemical compound C=1C=CC=NC=1C(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 XDHAIXLWGSULRW-UHFFFAOYSA-N 0.000 claims 1
- FWKRDGRNQGJQPD-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[(pyridine-3-carbonylamino)methyl]phenyl]acetic acid Chemical compound C=1C=CN=CC=1C(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 FWKRDGRNQGJQPD-UHFFFAOYSA-N 0.000 claims 1
- QXADRHMZWVAIAX-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[(pyridine-4-carbonylamino)methyl]phenyl]acetic acid Chemical compound C=1C=NC=CC=1C(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 QXADRHMZWVAIAX-UHFFFAOYSA-N 0.000 claims 1
- PJSOQGUCKVZZQP-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[[(2,4-dichlorophenyl)sulfonylamino]methyl]phenyl]acetic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 PJSOQGUCKVZZQP-UHFFFAOYSA-N 0.000 claims 1
- KUBRZCJYRQMUCL-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[[(4-fluorobenzoyl)amino]methyl]phenyl]acetic acid Chemical compound C=1C=C(F)C=CC=1C(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 KUBRZCJYRQMUCL-UHFFFAOYSA-N 0.000 claims 1
- COJBRJBTCYULNW-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-[[(4-fluorophenyl)sulfonylamino]methyl]phenyl]acetic acid Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 COJBRJBTCYULNW-UHFFFAOYSA-N 0.000 claims 1
- QAALQOVJHJFBLM-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorobenzoyl)amino]phenoxy]-3-methoxyphenyl]acetic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C(Cl)=C1 QAALQOVJHJFBLM-UHFFFAOYSA-N 0.000 claims 1
- QTDXYHSAWJVOEN-UHFFFAOYSA-N 2-[4-[4-[(3,4-dichlorophenyl)carbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=C(Cl)C(Cl)=CC=2)C=C1 QTDXYHSAWJVOEN-UHFFFAOYSA-N 0.000 claims 1
- YIWGQUJEAHOECZ-UHFFFAOYSA-N 2-[4-[4-[(3,4-difluorobenzoyl)amino]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(F)C(F)=C1 YIWGQUJEAHOECZ-UHFFFAOYSA-N 0.000 claims 1
- JDZOGRCMWAHPNM-UHFFFAOYSA-N 2-[4-[4-[(3-chloro-4-fluorophenyl)carbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=C(Cl)C(F)=CC=2)C=C1 JDZOGRCMWAHPNM-UHFFFAOYSA-N 0.000 claims 1
- NJBIYKYKBCPLQX-UHFFFAOYSA-N 2-[4-[4-[(3-chlorobenzoyl)amino]phenoxy]-3-[[(4-fluorophenyl)sulfonylamino]methyl]phenyl]acetic acid Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=CC(Cl)=C1 NJBIYKYKBCPLQX-UHFFFAOYSA-N 0.000 claims 1
- KUKXAEMVCOQUJW-UHFFFAOYSA-N 2-[4-[4-[(4-chloro-3-fluorophenyl)carbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NC=2C=C(F)C(Cl)=CC=2)C=C1 KUKXAEMVCOQUJW-UHFFFAOYSA-N 0.000 claims 1
- YFWSUBNOKZSEFJ-UHFFFAOYSA-N 2-[4-[4-[(4-chlorobenzoyl)amino]phenoxy]-3-[[(4-fluorophenyl)sulfonylamino]methyl]phenyl]acetic acid Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1NC(=O)C1=CC=C(Cl)C=C1 YFWSUBNOKZSEFJ-UHFFFAOYSA-N 0.000 claims 1
- DNLGOTSRLZRWNG-UHFFFAOYSA-N 2-[4-[4-[2-(3,4-dichlorophenyl)ethylcarbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=C(Cl)C(Cl)=CC=2)C=C1 DNLGOTSRLZRWNG-UHFFFAOYSA-N 0.000 claims 1
- HSDHWWKJICNYGR-UHFFFAOYSA-N 2-[4-[4-[2-(3-chlorophenyl)ethylcarbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=C(Cl)C=CC=2)C=C1 HSDHWWKJICNYGR-UHFFFAOYSA-N 0.000 claims 1
- PEZZDBHHHAQANH-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3,5-dimethylphenyl]acetic acid Chemical compound CC1=CC(CC(O)=O)=CC(C)=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 PEZZDBHHHAQANH-UHFFFAOYSA-N 0.000 claims 1
- JQGGGOAUJRAVHN-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-(3-methylsulfonylphenyl)phenyl]acetic acid Chemical compound CS(=O)(=O)C1=CC=CC(C=2C(=CC=C(CC(O)=O)C=2)OC=2C=CC(=CC=2)C(=O)NCCC=2C=CC(Cl)=CC=2)=C1 JQGGGOAUJRAVHN-UHFFFAOYSA-N 0.000 claims 1
- RBZBIJCEGRHONG-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-(4-methylsulfonylphenyl)phenyl]acetic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 RBZBIJCEGRHONG-UHFFFAOYSA-N 0.000 claims 1
- ZIQBBKHRQARKRT-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 ZIQBBKHRQARKRT-UHFFFAOYSA-N 0.000 claims 1
- ITATWACUKAVEJQ-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-[(dimethylamino)methyl]phenyl]acetic acid Chemical compound CN(C)CC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 ITATWACUKAVEJQ-UHFFFAOYSA-N 0.000 claims 1
- MLVVDNLQYQWNBQ-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-[(pyridin-3-ylsulfonylamino)methyl]phenyl]acetic acid Chemical compound C=1C=CN=CC=1S(=O)(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1 MLVVDNLQYQWNBQ-UHFFFAOYSA-N 0.000 claims 1
- NBTFNOPLJJLIOL-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-[(pyridine-3-carbonylamino)methyl]phenyl]acetic acid Chemical compound C=1C=CN=CC=1C(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1 NBTFNOPLJJLIOL-UHFFFAOYSA-N 0.000 claims 1
- SOKCIIYFIOXWBN-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-[[(3-methylimidazol-4-yl)sulfonylamino]methyl]phenyl]acetic acid Chemical compound CN1C=NC=C1S(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 SOKCIIYFIOXWBN-UHFFFAOYSA-N 0.000 claims 1
- UFBCIHJJPVYQHL-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-[[[2-[(4-fluorophenyl)sulfonylamino]acetyl]amino]methyl]phenyl]acetic acid Chemical compound C=1C=C(F)C=CC=1S(=O)(=O)NCC(=O)NCC1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1 UFBCIHJJPVYQHL-UHFFFAOYSA-N 0.000 claims 1
- OHCMQGQCROEVKM-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-[[methyl(methylsulfonyl)amino]methyl]phenyl]acetic acid Chemical compound CS(=O)(=O)N(C)CC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 OHCMQGQCROEVKM-UHFFFAOYSA-N 0.000 claims 1
- VJNMQMFRRYSIRC-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-cyanophenyl]-2-fluoroacetic acid Chemical compound N#CC1=CC(C(F)C(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 VJNMQMFRRYSIRC-UHFFFAOYSA-N 0.000 claims 1
- XLLQSQSPCLWIEQ-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 XLLQSQSPCLWIEQ-UHFFFAOYSA-N 0.000 claims 1
- KMNBLICUWBKLIH-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-cyanophenyl]propanoic acid Chemical compound N#CC1=CC(C(C(O)=O)C)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 KMNBLICUWBKLIH-UHFFFAOYSA-N 0.000 claims 1
- TXKOLAPCEKEYSJ-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-cyclopropylphenyl]acetic acid Chemical compound C1CC1C1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1 TXKOLAPCEKEYSJ-UHFFFAOYSA-N 0.000 claims 1
- IWZJHLCTTLLVPN-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-ethylphenyl]acetic acid Chemical compound CCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 IWZJHLCTTLLVPN-UHFFFAOYSA-N 0.000 claims 1
- GAYAWBNUMHZFRG-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-fluorophenyl]acetic acid Chemical compound FC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 GAYAWBNUMHZFRG-UHFFFAOYSA-N 0.000 claims 1
- UJPNEJNUMWNZDP-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-methoxyphenyl]acetic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 UJPNEJNUMWNZDP-UHFFFAOYSA-N 0.000 claims 1
- OVQBANWLFQETND-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-methylphenyl]acetic acid Chemical compound CC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 OVQBANWLFQETND-UHFFFAOYSA-N 0.000 claims 1
- AZHLDAIQQLBAOO-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-phenylphenyl]acetic acid Chemical compound C=1C=CC=CC=1C1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1 AZHLDAIQQLBAOO-UHFFFAOYSA-N 0.000 claims 1
- KFIDIFZVYZWNQI-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]-3-thiophen-2-ylphenyl]acetic acid Chemical compound C=1C=CSC=1C1=CC(CC(=O)O)=CC=C1OC(C=C1)=CC=C1C(=O)NCCC1=CC=C(Cl)C=C1 KFIDIFZVYZWNQI-UHFFFAOYSA-N 0.000 claims 1
- AFVSFZGYEQJQTC-UHFFFAOYSA-N 2-[4-[4-[2-(4-chlorophenyl)ethylcarbamoyl]phenoxy]phenyl]acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(Cl)=CC=2)C=C1 AFVSFZGYEQJQTC-UHFFFAOYSA-N 0.000 claims 1
- VXFWJJJIFUEHHS-UHFFFAOYSA-N 2-[4-[4-[2-(4-fluorophenyl)ethylcarbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCCC=2C=CC(F)=CC=2)C=C1 VXFWJJJIFUEHHS-UHFFFAOYSA-N 0.000 claims 1
- JTMGLPCBVZGXQJ-UHFFFAOYSA-N 2-[4-[4-[2-(4-tert-butylphenyl)ethylcarbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1CCNC(=O)C(C=C1)=CC=C1OC1=CC=C(CC(O)=O)C=C1C#N JTMGLPCBVZGXQJ-UHFFFAOYSA-N 0.000 claims 1
- PFHULMIUFRZOOK-UHFFFAOYSA-N 2-[4-[4-[2-(benzylamino)-2-oxoethyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1CC(=O)NCC1=CC=CC=C1 PFHULMIUFRZOOK-UHFFFAOYSA-N 0.000 claims 1
- HCBAPJIHNLBCLZ-UHFFFAOYSA-N 2-[4-[4-[2-[(4-chlorophenyl)methylamino]-2-oxoethyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC(C=C1)=CC=C1CC(=O)NCC1=CC=C(Cl)C=C1 HCBAPJIHNLBCLZ-UHFFFAOYSA-N 0.000 claims 1
- LGJGJLBKNKOLLS-UHFFFAOYSA-N 2-[4-[4-[2-[benzyl(methyl)amino]-2-oxoethyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound C=1C=C(OC=2C(=CC(CC(O)=O)=CC=2)CNS(C)(=O)=O)C=CC=1CC(=O)N(C)CC1=CC=CC=C1 LGJGJLBKNKOLLS-UHFFFAOYSA-N 0.000 claims 1
- ZASJPPYCBQIBPO-UHFFFAOYSA-N 2-[4-[4-[[1-(4-chlorophenyl)cyclopropyl]carbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NC2(CC2)C=2C=CC(Cl)=CC=2)C=C1 ZASJPPYCBQIBPO-UHFFFAOYSA-N 0.000 claims 1
- GNRRBHUAJFYMJW-UHFFFAOYSA-N 2-[4-[4-[[1-(4-chlorophenyl)cyclopropyl]methylcarbamoyl]phenoxy]-3-(methanesulfonamidomethyl)phenyl]acetic acid Chemical compound CS(=O)(=O)NCC1=CC(CC(O)=O)=CC=C1OC1=CC=C(C(=O)NCC2(CC2)C=2C=CC(Cl)=CC=2)C=C1 GNRRBHUAJFYMJW-UHFFFAOYSA-N 0.000 claims 1
- RAFIMVXAGIMWSH-UHFFFAOYSA-N 2-[4-[4-[[1-(4-chlorophenyl)cyclopropyl]methylcarbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NCC2(CC2)C=2C=CC(Cl)=CC=2)C=C1 RAFIMVXAGIMWSH-UHFFFAOYSA-N 0.000 claims 1
- QMLDPSITGQRFIJ-UHFFFAOYSA-N 2-[4-[4-[[2-(4-chlorophenyl)-2-hydroxyethyl]carbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound C=1C=C(Cl)C=CC=1C(O)CNC(=O)C(C=C1)=CC=C1OC1=CC=C(CC(O)=O)C=C1C#N QMLDPSITGQRFIJ-UHFFFAOYSA-N 0.000 claims 1
- MCNNHWUAJWKGNJ-UHFFFAOYSA-N 2-[4-[4-[[2-(4-chlorophenyl)cyclopropyl]carbamoyl]phenoxy]-3-cyanophenyl]acetic acid Chemical compound N#CC1=CC(CC(=O)O)=CC=C1OC1=CC=C(C(=O)NC2C(C2)C=2C=CC(Cl)=CC=2)C=C1 MCNNHWUAJWKGNJ-UHFFFAOYSA-N 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 0 Cc1c(*)cc(C=O)cc1BrC Chemical compound Cc1c(*)cc(C=O)cc1BrC 0.000 description 7
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83901806P | 2006-08-21 | 2006-08-21 | |
| US60/839,018 | 2006-08-21 | ||
| US85138506P | 2006-10-13 | 2006-10-13 | |
| US60/851,385 | 2006-10-13 | ||
| PCT/US2007/076378 WO2008024746A1 (en) | 2006-08-21 | 2007-08-21 | 4-substituted phenoxyphenylacetic acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010501587A JP2010501587A (ja) | 2010-01-21 |
| JP2010501587A5 true JP2010501587A5 (US07132539-20061107-C00040.png) | 2010-09-24 |
| JP5582634B2 JP5582634B2 (ja) | 2014-09-03 |
Family
ID=38904570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009525728A Expired - Fee Related JP5582634B2 (ja) | 2006-08-21 | 2007-08-21 | ４−置換フェノキシフェニル酢酸誘導体 |
Country Status (25)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2463292C2 (ru) * | 2006-08-21 | 2012-10-10 | Эррэй Биофарма Инк. | Производные 4-замещенной феноксифенилуксусной кислоты |
| WO2008116145A2 (en) * | 2007-03-22 | 2008-09-25 | Arete Therapeutics, Inc. | Soluble epoxide hydrolase inhibitors |
| US8362056B2 (en) * | 2007-11-05 | 2013-01-29 | Array Biopharma Inc. | 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives |
| US8168678B2 (en) | 2008-02-01 | 2012-05-01 | Panmira Pharmaceuticals, Inc. | N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors |
| WO2009102893A2 (en) * | 2008-02-14 | 2009-08-20 | Amira Pharmaceuticals, Inc. | CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors |
| US8497381B2 (en) | 2008-02-25 | 2013-07-30 | Panmira Pharmaceuticals, Llc | Antagonists of prostaglandin D2 receptors |
| WO2009145989A2 (en) | 2008-04-02 | 2009-12-03 | Amira Pharmaceuticals, Inc. | Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| AU2009262274B2 (en) * | 2008-06-25 | 2013-08-01 | Array Biopharma Inc. | 6-substituted phenoxychroman carboxylic acid derivatives |
| BRPI0913930A2 (pt) | 2008-07-03 | 2015-10-20 | Amira Pharmaceuticals Inc | antagonistas de receptores de prostaglandinas d2 |
| GB2463788B (en) | 2008-09-29 | 2010-12-15 | Amira Pharmaceuticals Inc | Heteroaryl antagonists of prostaglandin D2 receptors |
| US8378107B2 (en) | 2008-10-01 | 2013-02-19 | Panmira Pharmaceuticals, Llc | Heteroaryl antagonists of prostaglandin D2 receptors |
| WO2010042652A2 (en) | 2008-10-08 | 2010-04-15 | Amira Pharmaceuticals, Inc. | Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors |
| WO2010057118A2 (en) | 2008-11-17 | 2010-05-20 | Amira Pharmaceuticals, Inc. | Heterocyclic antagonists of prostaglandin d2 receptors |
| CA2748099C (en) * | 2008-12-22 | 2017-02-28 | Array Biopharma Inc. | 7-phenoxychroman carboxylic acid derivatives |
| PE20120655A1 (es) | 2009-02-17 | 2012-06-07 | Chiesi Farma Spa | Derivados de triazolopiridina como inhibidores de proteinas cinasas activadas por mitogeno p38 (map) |
| KR20120038544A (ko) | 2009-07-31 | 2012-04-23 | 판미라 파마슈티칼스, 엘엘씨 | Ｄｐ2 수용체 길항제의 안과용 약학 조성물 |
| JP2013501052A (ja) | 2009-08-05 | 2013-01-10 | パンミラ ファーマシューティカルズ，エルエルシー． | Ｄｐ２アンタゴニストおよびその用途 |
| CA2782085A1 (en) * | 2010-01-06 | 2011-07-14 | Panmira Pharmaceuticals, Llc | Dp2 antagonist and uses thereof |
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| EP2526945A1 (en) | 2011-05-25 | 2012-11-28 | Almirall, S.A. | New CRTH2 Antagonists |
| EP2548876A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists |
| EP2548863A1 (en) | 2011-07-18 | 2013-01-23 | Almirall, S.A. | New CRTh2 antagonists. |
| BR112014014558A8 (pt) | 2011-12-16 | 2017-07-04 | Atopix Therapeutics Ltd | composição farmacêutica, uso de um antagonista de crth2 e de um inibidor de bomba de prótons, e, kit para o tratamento de esofagite eosinofílica |
| CN104016878B (zh) * | 2014-06-24 | 2015-06-10 | 中国药科大学 | 芳基乙酸类衍生物、其制备方法及其医药用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1127046A1 (de) * | 1998-11-04 | 2001-08-29 | Basf Aktiengesellschaft | 2-phenoxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung und sie enthaltende mittel zur bekämpfung von schadpilzen |
| JP2001072653A (ja) * | 1999-07-01 | 2001-03-21 | Taisho Pharmaceut Co Ltd | アミノ安息香酸誘導体 |
| GB0015205D0 (en) | 2000-06-21 | 2000-08-09 | Karobio Ab | Bioisosteric thyroid receptor ligands and method |
| JP2002193800A (ja) * | 2000-12-22 | 2002-07-10 | Taisho Pharmaceut Co Ltd | Ｖｅｇｆ受容体拮抗剤 |
| EP2565178A1 (en) * | 2002-10-03 | 2013-03-06 | Ono Pharmaceutical Co., Ltd. | LPA Receptor Antagonists |
| BR0317591A (pt) * | 2002-12-20 | 2005-11-22 | Amgen Inc | Composto, sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, métodos para tratar uma doença ou condição, para modular a função de crth2 e/ou um ou mais outros receptores de pgd2 em uma célula e para modular crth2 e/ou um ou mais outros receptores de pgd2 |
| US7557143B2 (en) * | 2003-04-18 | 2009-07-07 | Bristol-Myers Squibb Company | Thyroid receptor ligands |
| GB0415320D0 (en) | 2004-07-08 | 2004-08-11 | Astrazeneca Ab | Novel compounds |
| RU2416608C2 (ru) * | 2004-08-06 | 2011-04-20 | Оцука Фармасьютикал Ко., Лтд. | Ароматическое соединение |
| EP2044044A2 (en) | 2006-06-09 | 2009-04-08 | Icos Corporation | Substituted phenyl acetic acids as dp-2 antagonists |
| RU2463292C2 (ru) * | 2006-08-21 | 2012-10-10 | Эррэй Биофарма Инк. | Производные 4-замещенной феноксифенилуксусной кислоты |
-
2007
- 2007-08-21 RU RU2009110183/04A patent/RU2463292C2/ru not_active IP Right Cessation
- 2007-08-21 AU AU2007286829A patent/AU2007286829B2/en not_active Ceased
- 2007-08-21 BR BRPI0715617-0A2A patent/BRPI0715617A2/pt not_active IP Right Cessation
- 2007-08-21 MX MX2009001876A patent/MX2009001876A/es active IP Right Grant
- 2007-08-21 SI SI200731117T patent/SI2057115T1/sl unknown
- 2007-08-21 US US12/438,112 patent/US8183289B2/en not_active Expired - Fee Related
- 2007-08-21 PL PL07814294T patent/PL2057115T3/pl unknown
- 2007-08-21 NZ NZ575507A patent/NZ575507A/en not_active IP Right Cessation
- 2007-08-21 JP JP2009525728A patent/JP5582634B2/ja not_active Expired - Fee Related
- 2007-08-21 UA UAA200902429A patent/UA96459C2/uk unknown
- 2007-08-21 WO PCT/US2007/076378 patent/WO2008024746A1/en active Application Filing
- 2007-08-21 CA CA2661164A patent/CA2661164C/en not_active Expired - Fee Related
- 2007-08-21 RS RS20120563A patent/RS52627B/en unknown
- 2007-08-21 TW TW096130898A patent/TWI409247B/zh not_active IP Right Cessation
- 2007-08-21 CN CNA200780039235XA patent/CN101553461A/zh active Pending
- 2007-08-21 MY MYPI20090706A patent/MY149934A/en unknown
- 2007-08-21 PT PT78142940T patent/PT2057115E/pt unknown
- 2007-08-21 ES ES07814294T patent/ES2396715T3/es active Active
- 2007-08-21 DK DK07814294.0T patent/DK2057115T3/da active
- 2007-08-21 EP EP07814294A patent/EP2057115B9/en active Active
- 2007-08-21 SG SG2011057858A patent/SG174069A1/en unknown
- 2007-08-21 KR KR1020097005733A patent/KR101397352B1/ko not_active IP Right Cessation
-
2009
- 2009-02-19 IL IL197135A patent/IL197135A/en active IP Right Grant
- 2009-03-12 CO CO09025722A patent/CO6160224A2/es unknown
-
2012
- 2012-04-17 US US13/448,689 patent/US8492437B2/en not_active Expired - Fee Related
-
2013
- 2013-01-03 HR HRP20130004TT patent/HRP20130004T8/hr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010501587A5 (US07132539-20061107-C00040.png) | ||
| IL197135A (en) | The phenoxyphenylacetic acid derivatives are preserved in position 4, preparations containing them, their uses and methods for preparing them | |
| EP0686625B1 (en) | Anthranilic acid derivative | |
| JP5498786B2 (ja) | 新規なマロン酸スルホンアミド誘導体およびその医薬用途 | |
| HRP20181076T1 (hr) | Pirazolski derivati kao modulatori kalcijevih kanala aktiviranih oslobađanjem kalcija | |
| JP2015517981A5 (US07132539-20061107-C00040.png) | ||
| JP2004525951A5 (US07132539-20061107-C00040.png) | ||
| JP2001526223A (ja) | 置換複素環尿素を用いるｐ３８キナーゼの阻害 | |
| EP1302463A1 (en) | Medicine comprising dicyanopyridine derivative | |
| JP2010508318A (ja) | Ｌ−ｃｐｔ１阻害剤として有用なインダゾール誘導体 | |
| TW200800200A (en) | Medicinal drug | |
| JPH09509654A (ja) | サイクリックａｍｐホスホジエステラーゼおよびｔｎｆ阻害剤としての置換芳香族化合物 | |
| JP2002516314A5 (US07132539-20061107-C00040.png) | ||
| JP2002179594A (ja) | タチキニンｎｋ３受容体アンタゴニストとしてのキノリン誘導体 | |
| JP2004504301A5 (US07132539-20061107-C00040.png) | ||
| RU2009116670A (ru) | Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина | |
| JP2007519692A5 (US07132539-20061107-C00040.png) | ||
| JP2003535900A (ja) | ベンズアミド誘導体の治療薬としての使用 | |
| WO2001025190A1 (fr) | Nouveaux derives de diarylamide et utilisation de ces composes comme medicaments | |
| JP2009517368A5 (US07132539-20061107-C00040.png) | ||
| CA2626402A1 (en) | Potassium channel inhibitors | |
| JP2008524157A5 (US07132539-20061107-C00040.png) | ||
| JP2008526988A5 (US07132539-20061107-C00040.png) | ||
| EP1666469A1 (en) | Plasminogen activator inhibitor-1 inhibitor | |
| JP2007261945A (ja) | チアゾール誘導体 |
